Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions

European Journal of Clinical Investigation

Volumn 34, Issue 11, 2004, Pages 774-781

  Cohen, Gerald ^a   Horl W H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute renal failure; Apoptosis; Chemotaxis; Oxidative metabolism; Polymorphonuclear leucocytes; Retinol binding protein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AGAROSE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; POLYACRYLONITRILE; PROPIDIUM IODIDE; RETINOL BINDING PROTEIN;

ACUTE KIDNEY FAILURE; AEROBIC METABOLISM; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATOGRAPHY; CONCENTRATION RESPONSE; DNA CONTENT; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNE RESPONSE; ION EXCHANGE CHROMATOGRAPHY; LEUKOCYTE FUNCTION; MASS SPECTROMETRY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; UREMIA;

APOPTOSIS; CHEMOTAXIS, LEUKOCYTE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; HUMANS; IMIDAZOLES; KIDNEY FAILURE, ACUTE; MALE; NEUTROPHILS; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PYRIDINES; RETINOL-BINDING PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 8744288331     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01418.x     Document Type: Article

References (34)

1. Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M et al. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991;18:326-35.
2. Himmelfarb J, Hakim RM. Biocompatibility and risk of infection in haemodialysis patients. Nephrol Dial Transplant 1994;9:138-44.
3. Vanholder R, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G et al. Uremic toxicity: present state of the art. Int J Artif Organs 2001;24:695-725.
4. Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997;62:S79-82.
5. Cohen G, Haag-Weber M, Mai B, Deicher R, Hörl WH. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995;6:1592-9.
6. Rask L, Anundi H, Bohme J, Eriksson U, Fredriksson A, Nilsson SF et al. The retinol-binding protein. Scand J Clin Lab Invest Suppl 1980;154:45-61.
7. Nelson RD, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975;115:1650-6.
8. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R et al. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 1984;259:5430-9.
9. Goldstein IM. Chemotactic factor receptors on leukocytes - scratching the surface. J Lab Clin Med 1981;97:599-601.
10. Jaconi S, Saurat JH, Siegenthaler G. Analysis of normal and truncated holo- and apo-retinol-binding protein (RBP) in human serum: altered ratios in chronic renal failure. Eur J Endocrinol 1996;134:576-82.
11. Noy N. Retinoid-binding proteins: mediators of retinoid action. Biochem J 2000;348:481-95.
12. Stein G, Schone S, Geinitz D, Abendroth K, Kokot F, Fünfstück R et al. No tissue level abnormality of vitamin A concentration despite elevated serum vitamin A of uremic patients. Clin Nephrol 1986;25:87-93.
13. Smith FR, Goodman DS. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 1971;50:2426-36.
14. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, van Ypersele de Strihou C, Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 1994;45:1689-96.
15. Siegenthaler G, Saurat JH. Retinol-binding protein in human serum: conformational changes induced by retinoic acid binding. Biochem Biophys Res Commun 1987;143:418-23.
16. Naylor HM, Newcomer ME. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 1999;38:2647-53.
17. Siegenthaler G. Extra-and intracellular transport of retinoids: a reappraisal. Horm Res 1996;45:122-7.
18. Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay. Biochem Biophys Res Commun 2002;297:401-5.
19. Vannucchi MT, Vannucchi H, Humphreys M. Serum levels of vitamin A and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis. Int J Vitam Nutr Res 1992;62:107-12.
20. Scarpioni L, Dall'aglio PP, Poisetti PG, Buzio C. Retinol binding protein in serum and in urine of glomerular and tubular nephropathies. Clin Chim Acta 1976;68:107-13.
21. Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta2-microglobulin, and retinol-binding protein as indicators of glomerular nitration rate: comparison with plasma creatinine. J Pharm Biomed Anal 2001;24:835-42.
22. Bankson DD, Rifai N, Silverman LM. Serum retinol-binding protein and creatinine in onset of and recovery from acute renal failure. Clin Chem 1987;33:1942.
23. Gerlach TH, Zile MH. Effect of retinoic acid and apo-RBP on serum retinol concentration in acute renal failure. Faseb J 1991;5:86-92.
24. Martin RR, Eknoyan G, Saenz C, Hyde SE. 3rd, Olivero J. Effects of renal failure on leukotaxis. J Med 1979;10:267-78.
25. Bavik CO, Eriksson U, Allen RA, Peterson PA. Identification and partial characterization of a retinal pigment epithelial membrane receptor for plasma retinol-binding protein. J Biol Chem 1991;266:14978-85.
26. Sundaram M, Sivaprasadarao A, DeSousa MM, Findlay JB. The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J Biol Chem 1998;273:3336-42.
27. Zhou MJ, Brown EJ. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation. J Cell Biol 1994;125:1407-16.
28. Forsberg M, Druid P, Zheng L, Stendahl O, Sarndahl E. Activation of Rac2 and Cdc42 on Fc and complement receptor ligation in human neutrophils. J Leukoc Biol 2003;74:611-9.
29. McLeish KR, Klein JB, Coxon PY, Head KZ, Ward RA. Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J Leukoc Biol 1998;64:835-44.
30. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
31. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-6.
32. Cohen G, Rudnicki M, Deicher R, Hörl WH. Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. Eur J Clin Invest 2003;33:669-76.
33. Gardai S, Whitlock BB, Helgason C, Ambruso D, Fadok V, Bratton D et al. Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J Biol Chem 2002;277:5236-46.
34. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997;89:1748-53.